Physician profile
Mark Frederick Deatherage
NPI 1841293156
$331.30
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2020: $178 · 2021: $15.33.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $125.00 | 2020 | |
| Janssen Pharmaceuticals, INC | $72.49 | 2019-2021 | |
| Medtronic Vascular, INC. | $50.58 | 2019 | |
| Davol INC. | $20.97 | 2019 | |
| Venclose INC. | $18.60 | 2020 | |
| Tactile Systems Technology INC | $17.17 | 2020 | |
| Lemaitre Vascular, INC. | $14.32 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $12.17 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Deatherage listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.